EP3188748A4 - Composition immunogène dirigée contre campylobacter jejuni - Google Patents
Composition immunogène dirigée contre campylobacter jejuni Download PDFInfo
- Publication number
- EP3188748A4 EP3188748A4 EP15830474.1A EP15830474A EP3188748A4 EP 3188748 A4 EP3188748 A4 EP 3188748A4 EP 15830474 A EP15830474 A EP 15830474A EP 3188748 A4 EP3188748 A4 EP 3188748A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunogenic composition
- campylobacter jejuni
- composition against
- against campylobacter
- jejuni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462034436P | 2014-08-07 | 2014-08-07 | |
US201462054454P | 2014-09-24 | 2014-09-24 | |
US201562165301P | 2015-05-22 | 2015-05-22 | |
PCT/US2015/043070 WO2016022412A1 (fr) | 2014-08-07 | 2015-07-31 | Composition immunogène dirigée contre campylobacter jejuni |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3188748A1 EP3188748A1 (fr) | 2017-07-12 |
EP3188748A4 true EP3188748A4 (fr) | 2018-04-18 |
Family
ID=55264367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15830474.1A Pending EP3188748A4 (fr) | 2014-08-07 | 2015-07-31 | Composition immunogène dirigée contre campylobacter jejuni |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3188748A4 (fr) |
JP (1) | JP6530051B2 (fr) |
AU (2) | AU2015301368B2 (fr) |
CA (1) | CA2957430C (fr) |
WO (1) | WO2016022412A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117347415B (zh) * | 2023-09-22 | 2024-10-01 | 江苏国源先进仪器技术研究院有限公司 | 一种基于高场核磁共振技术鉴定多肽药物二硫键的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005020964A1 (fr) * | 2003-06-02 | 2005-03-10 | Chiron Corporation | Compositions immunogenes basees sur des microparticules comprenant des antigenes contenant de l'anatoxine adsorbee et des polysaccharides |
WO2007038122A2 (fr) * | 2005-09-21 | 2007-04-05 | The United States Of America As Represented By The Secretary Of The Navy | Composition d'une capsule immunogenique utilisee comme composant d'un vaccin contre campylobacter jejuni |
WO2009017666A1 (fr) * | 2007-07-27 | 2009-02-05 | The United States Of America As Represented By The Secretary Of The Navy | Composition de capsule pour une utilisation en tant qu'immunogène contre campylobacter jejuni |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9308246B2 (en) * | 2010-05-28 | 2016-04-12 | The United States Of America As Represented By The Secretary Of The Navy | Capsule composition for use as immunogen against Campylobacter jejuni |
CA2961883C (fr) * | 2014-09-24 | 2023-10-03 | The United States Of America As Represented By The Secretary Of The Navy | Construction recombinee combinant les bacteries escherichia coli enterotoxinogene et campylobacter jejuni |
-
2015
- 2015-07-31 WO PCT/US2015/043070 patent/WO2016022412A1/fr active Application Filing
- 2015-07-31 AU AU2015301368A patent/AU2015301368B2/en active Active
- 2015-07-31 JP JP2017506284A patent/JP6530051B2/ja active Active
- 2015-07-31 EP EP15830474.1A patent/EP3188748A4/fr active Pending
- 2015-07-31 CA CA2957430A patent/CA2957430C/fr active Active
-
2018
- 2018-06-14 AU AU2018204255A patent/AU2018204255B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005020964A1 (fr) * | 2003-06-02 | 2005-03-10 | Chiron Corporation | Compositions immunogenes basees sur des microparticules comprenant des antigenes contenant de l'anatoxine adsorbee et des polysaccharides |
WO2007038122A2 (fr) * | 2005-09-21 | 2007-04-05 | The United States Of America As Represented By The Secretary Of The Navy | Composition d'une capsule immunogenique utilisee comme composant d'un vaccin contre campylobacter jejuni |
WO2009017666A1 (fr) * | 2007-07-27 | 2009-02-05 | The United States Of America As Represented By The Secretary Of The Navy | Composition de capsule pour une utilisation en tant qu'immunogène contre campylobacter jejuni |
Non-Patent Citations (6)
Title |
---|
ANDREY V KARLYSHEV ET AL: "Analysis of Campylobacter jejuni Capsular Loci Reveals Multiple Mechanisms for the Generation of Structural Diversity and the Ability to Form Complex Heptoses", MOLECULAR MICROBIOL, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 55, no. 1, 1 January 2005 (2005-01-01), pages 90 - 103, XP008126621, ISSN: 0950-382X, DOI: 10.1111/J.1365-2958.2004.04374.X * |
F. POLY ET AL: "Discrimination of Major Capsular Types of Campylobacter jejuni by Multiplex PCR", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 49, no. 5, 16 March 2011 (2011-03-16), pages 1750 - 1757, XP055069851, ISSN: 0095-1137, DOI: 10.1128/JCM.02348-10 * |
MARTINE C. HOLST SØRENSEN ET AL: "Phase Variable Expression of Capsular Polysaccharide Modifications Allows Campylobacter jejuni to Avoid Bacteriophage Infection in Chickens", FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, vol. 2, 20 February 2012 (2012-02-20), pages 1 - 11, XP055429225, DOI: 10.3389/fcimb.2012.00011 * |
PAPP-SZABO ET AL: "Cell-surface @a-glucan in Campylobacter jejuni 81-176", CARBOHYDRATE RESE, PERGAMON, GB, vol. 340, no. 13, 26 September 2005 (2005-09-26), pages 2218 - 2221, XP005032116, ISSN: 0008-6215, DOI: 10.1016/J.CARRES.2005.06.023 * |
REDKYNA ET AL: "A vaccine against Campylobacter jejuni serotype HS:5", 3 January 2014 (2014-01-03), pages 1 - 101, XP009503578, Retrieved from the Internet <URL:http://hdl.handle.net/10214/7740> * |
See also references of WO2016022412A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU2015301368A1 (en) | 2017-02-09 |
AU2018204255A1 (en) | 2018-07-05 |
WO2016022412A8 (fr) | 2017-04-20 |
CA2957430A1 (fr) | 2016-02-11 |
CA2957430C (fr) | 2021-01-12 |
WO2016022412A1 (fr) | 2016-02-11 |
AU2018204255B2 (en) | 2019-04-18 |
JP2017524710A (ja) | 2017-08-31 |
JP6530051B2 (ja) | 2019-06-12 |
WO2016022412A9 (fr) | 2016-05-12 |
AU2015301368B2 (en) | 2018-04-05 |
EP3188748A1 (fr) | 2017-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201702202B (en) | Capsule composition | |
EP3040326A4 (fr) | Composition d'halogéno-oléfine | |
EP3398996A4 (fr) | Composition | |
EP3339331A4 (fr) | Composition | |
EP3281534A4 (fr) | Composition édulcorante contenant de l'érythritol | |
EP3210613A4 (fr) | Composition pour application externe | |
EP3067338A4 (fr) | Composition durcissable à l'eau | |
EP3248475A4 (fr) | Composition | |
EP3221420A4 (fr) | Compositions photochromes-électrochromes | |
EP3221345A4 (fr) | Compositions de métalloprotéines | |
EP3100742A4 (fr) | Composition d'agent anticancéreux | |
EP3287010A4 (fr) | Composition destinée à améliorer la texture des aliments | |
EP3231430A4 (fr) | Composition | |
EP3137629A4 (fr) | Compositions et procédés de détection de la maladie du huanglongbing | |
EP3191110A4 (fr) | Composition de polygalacturonan rhamnogalacturonane (pgrg1) | |
EP3369418A4 (fr) | Composition | |
EP3125321A4 (fr) | Composition filmogène organique semi-conductrice | |
EP3366730A4 (fr) | Composition d'encre à base d'eau | |
EP3228322B8 (fr) | Composition d'adjuvant | |
EP3162223A4 (fr) | Composition de boisson | |
EP3138569A4 (fr) | Composition d'application externe | |
EP3322295A4 (fr) | Composition | |
EP3237399A4 (fr) | Composés, compositions et procédés | |
EP3214161A4 (fr) | Composition d'agent de nettoyage | |
IL249151B (en) | A preparation for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/02 20060101ALI20171208BHEP Ipc: A61K 39/385 20060101ALI20171208BHEP Ipc: A61K 39/00 20060101AFI20171208BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20180320 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/00 20060101AFI20180314BHEP Ipc: A61K 39/02 20060101ALI20180314BHEP Ipc: A61K 39/385 20060101ALI20180314BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200318 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |